These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 15525529)
1. The APC tumor suppressor binds to C-terminal binding protein to divert nuclear beta-catenin from TCF. Hamada F; Bienz M Dev Cell; 2004 Nov; 7(5):677-85. PubMed ID: 15525529 [TBL] [Abstract][Full Text] [Related]
2. C-terminal-binding protein directly activates and represses Wnt transcriptional targets in Drosophila. Fang M; Li J; Blauwkamp T; Bhambhani C; Campbell N; Cadigan KM EMBO J; 2006 Jun; 25(12):2735-45. PubMed ID: 16710294 [TBL] [Abstract][Full Text] [Related]
3. The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes. Sierra J; Yoshida T; Joazeiro CA; Jones KA Genes Dev; 2006 Mar; 20(5):586-600. PubMed ID: 16510874 [TBL] [Abstract][Full Text] [Related]
4. HMG box transcription factor TCF-4's interaction with CtBP1 controls the expression of the Wnt target Axin2/Conductin in human embryonic kidney cells. Valenta T; Lukas J; Korinek V Nucleic Acids Res; 2003 May; 31(9):2369-80. PubMed ID: 12711682 [TBL] [Abstract][Full Text] [Related]
5. APC 3 x 15 beta-catenin-binding domain potentiates beta-catenin association to TBP and upregulates TCF-4 transcriptional activity. Roura S; Martínez D; Piedra J; Miravet S; García de Herreros A; Duñach M Biochem Biophys Res Commun; 2003 Oct; 309(4):830-5. PubMed ID: 13679048 [TBL] [Abstract][Full Text] [Related]
7. Crystal structure of a beta-catenin/APC complex reveals a critical role for APC phosphorylation in APC function. Xing Y; Clements WK; Le Trong I; Hinds TR; Stenkamp R; Kimelman D; Xu W Mol Cell; 2004 Aug; 15(4):523-33. PubMed ID: 15327769 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells. Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511 [TBL] [Abstract][Full Text] [Related]
9. TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling. Brantjes H; Barker N; van Es J; Clevers H Biol Chem; 2002 Feb; 383(2):255-61. PubMed ID: 11934263 [TBL] [Abstract][Full Text] [Related]
10. APC mutations in colorectal tumours from FAP patients are selected for CtBP-mediated oligomerization of truncated APC. Schneikert J; Brauburger K; Behrens J Hum Mol Genet; 2011 Sep; 20(18):3554-64. PubMed ID: 21665989 [TBL] [Abstract][Full Text] [Related]
11. Hot spots in beta-catenin for interactions with LEF-1, conductin and APC. von Kries JP; Winbeck G; Asbrand C; Schwarz-Romond T; Sochnikova N; Dell'Oro A; Behrens J; Birchmeier W Nat Struct Biol; 2000 Sep; 7(9):800-7. PubMed ID: 10966653 [TBL] [Abstract][Full Text] [Related]
12. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898 [TBL] [Abstract][Full Text] [Related]
13. Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion. Faux MC; Ross JL; Meeker C; Johns T; Ji H; Simpson RJ; Layton MJ; Burgess AW J Cell Sci; 2004 Jan; 117(Pt 3):427-39. PubMed ID: 14679305 [TBL] [Abstract][Full Text] [Related]
14. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin. Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025 [TBL] [Abstract][Full Text] [Related]
15. Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of beta-catenin. Regulation by histone deacetylase 1. Henderson BR; Galea M; Schuechner S; Leung L J Biol Chem; 2002 Jul; 277(27):24258-64. PubMed ID: 11986304 [TBL] [Abstract][Full Text] [Related]
16. The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression. Shih IM; Yu J; He TC; Vogelstein B; Kinzler KW Cancer Res; 2000 Mar; 60(6):1671-6. PubMed ID: 10749138 [TBL] [Abstract][Full Text] [Related]
17. Differences between the interaction of beta-catenin with non-phosphorylated and single-mimicked phosphorylated 20-amino acid residue repeats of the APC protein. Tickenbrock L; Kössmeier K; Rehmann H; Herrmann C; Müller O J Mol Biol; 2003 Mar; 327(2):359-67. PubMed ID: 12628243 [TBL] [Abstract][Full Text] [Related]
18. Identification of Tcf4 residues involved in high-affinity beta-catenin binding. Omer CA; Miller PJ; Diehl RE; Kral AM Biochem Biophys Res Commun; 1999 Mar; 256(3):584-90. PubMed ID: 10080941 [TBL] [Abstract][Full Text] [Related]
19. Transforming activity and therapeutic targeting of C-terminal-binding protein 2 in Apc-mutated neoplasia. Sumner ET; Chawla AT; Cororaton AD; Koblinski JE; Kovi RC; Love IM; Szomju BB; Korwar S; Ellis KC; Grossman SR Oncogene; 2017 Aug; 36(33):4810-4816. PubMed ID: 28414304 [TBL] [Abstract][Full Text] [Related]
20. Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription. Song LN; Herrell R; Byers S; Shah S; Wilson EM; Gelmann EP Mol Cell Biol; 2003 Mar; 23(5):1674-87. PubMed ID: 12588987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]